ServiceNow Boosts 2025 Outlook Amid Solid Q1 Growth

Published 1 hours agoNOW

ServiceNow Boosts 2025 Outlook Amid Solid Q1 Growth

ServiceNow reported a robust 19% increase in Q1 2025 subscription revenues, reaching $3.005 billion, with a 20% rise in constant currency. This reflects the company's ongoing capacity to generate strong growth in its subscription-based model.

The company raised its full-year 2025 subscription revenue guidance to between $12.64 billion and $12.68 billion, surpassing initial estimates. According to Insider Monkey, this upward revision underscores ServiceNow's confidence in achieving its annual growth target of 19.5%, highlighting positive sentiment in the tech market. This announcement prompted a boost in ServiceNow's shares during post-market trading, as investors responded to the optimistic outlook.

ServiceNow emphasized its strength in AI-driven business transformation, reporting 72 substantial transactions with over $1 million in new annual contract value (ACV) in the first quarter. Despite global economic challenges like tariffs, ServiceNow remains positive about its ability to sustain strong demand, reflecting its strategic resilience and market adaptability.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Robert Half Projects Lower Q2 Revenue, Reflecting Cautious Market

Robert Half Projects Lower Q2 Revenue, Reflecting Cautious Market

17 minutes agoRHI

Robert Half has forecasted its second-quarter revenue to range between $1.31 billion and $1.41 billion, falling short of analysts' expectations of $1.46 billion. This subdued outlook underscores a cautious market environment amid economic uncertainties. The company's first-quarter performance saw revenues drop to $1.352 billion, marking an 8% decline from the previous year. Net income took a significant hit, plummeting to $17 million, or $0.17 per share, from $64 million in Q1 2024. According to Insightia, these results reflect prolonged decision-making cycles in the market driven by apprehensions over U.S. trade and policy. Robert Half's business segments reveal mixed performance, with Contract Talent Solutions revenues declining by 13% year-over-year in March and 12% in early April. Permanent Placement saw a 10% drop in March but showed signs of recovery in April with only a 2% reduction from the prior year. The company attributes these trends to cautious hiring practices in light of ongoing economic factors.

Moelis & Company Fortifies Private Funds Advisory With Strategic Hires

Moelis & Company Fortifies Private Funds Advisory With Strategic Hires

32 minutes agoMC

Moelis & Company has announced the appointment of Matt Wesley as the Global Head of Private Funds Advisory as of February 2025. This strategic move highlights the firm's dedication to bolstering its offerings in the private capital sector, an area gaining significant attention for its potential market dynamism. Wesley's role includes supporting the firm's private equity clients throughout their lifecycle, aligning with the company's expansion goals. The firm reported a substantial revenue increase of 41% in the first quarter of 2025, underscoring its focus on enhancing private funds and strengthening advisory services. This strong financial performance is attributed to Moelis & Company's ongoing efforts to develop a comprehensive private capital platform. The commitment to expansion signifies the company's intention to solidify its position in the private capital advisory market. In addition to Wesley's appointment, Moelis has strategically enhanced its team with key hires. Julien Oussadon joins as a Managing Director to expand the global technology segment, while Christopher Callesano steps in as Chief Financial Officer, following Joseph Simon's departure. As reported by Insider Monkey, these appointments reflect the firm's broader strategy to improve its financial advisory capabilities across vital sectors like technology and private funds to drive sustainable growth.

Edwards Lifesciences Raises 2025 Sales Outlook Amid Strong Segment Performance

Edwards Lifesciences Raises 2025 Sales Outlook Amid Strong Segment Performance

Edwards Lifesciences has revised its 2025 sales guidance upward to a range of $5.7 billion to $6.1 billion, sustaining an 8–10% constant currency growth projection. The increase reflects a strong performance across its business segments, particularly emphasizing its commitment to maintain competitive leadership and stable pricing in the market. The company's Transcatheter Mitral and Tricuspid Therapies (TMTT) segment has shown significant growth, prompting a sales guidance increase to $530–550 million for 2025, up from the previous $500–530 million projection. The Transcatheter Aortic Valve Replacement (TAVR) sales continue to be a major revenue contributor, hitting $1.04 billion in Q4 2024, representing a 6% year-over-year increase and accounting for $4.1 billion in annual sales. Edwards Lifesciences' strategic focus is on segments like Structural Heart Failure and Aortic Regurgitation, identified as key growth areas. Supporting this strategy, the company reported 6.2% sales growth in Q1 2025, totaling $1.41 billion, with TAVR sales up by 3.8% and TMTT surging by 58% to $115 million. Adjusted EPS for 2025 remains forecasted at $2.40–$2.50, with Q1 adjusted EPS at $0.64. Regulatory advancements include SAPIEN M3 CE Mark approval and expanded U.S. coverage for EVOQUE tricuspid valve replacement, underscoring Edwards' ongoing efforts in innovation and market expansion.

Lam Research Projects Robust Q2 2025 Revenue Growth

Lam Research Projects Robust Q2 2025 Revenue Growth

1 hours agoLRCX

Lam Research has set an ambitious revenue forecast for the second quarter of 2025 at $5 billion, driven by substantial upgrades in the NAND memory sector. The company attributes its expected growth to the demand for advanced fabrication equipment necessary for the evolving NAND technology landscape. Advancements in the NAND market are a key driver for Lam Research, as two-thirds of the industry's equipment requires updates. As manufacturers transition to higher-layer NAND technology, exceeding 200 layers, the need for sophisticated techniques such as cryo etch and Moly deposition becomes crucial. Insider Monkey notes that this shift positions Lam to potentially benefit from a $40 billion upgrade cycle. Despite the promising outlook, there are industry-wide challenges, including NAND flash memory oversupply and price declines. Lam Research's recent earnings report, however, demonstrates resilience, showing a 16% revenue growth in Q4 2024 to nearly $4.4 billion, surpassing market expectations. This performance lays a strong groundwork for the company's future projections.